From Prototype to Profit: Commercialization Insights

At OCP EMEA 2026, MiTAC showcases new liquid-cooled OCP servers and open-source integrations designed to build more sustainable, high-performance data centers.

Massive Bio and OpenAI launch a groundbreaking AI initiative to automate patient matching for clinical trials, aiming to boost health equity and speed up research.

A new federal initiative aims to eliminate paper forms in clinics, giving patients control over their health data with a simple QR code. Here's how it works.

With its Q1 2026 results imminent, the parent of Betway and Spin faces scrutiny to see if its global strategy can uphold its stellar financial momentum.

Graybill Medical Group cut front-office costs by $3M and erased patient wait times by partnering with AI firm Third Way Health for a major transformation.

Following a successful trial with Opera, adMarketplace's new AI Discover program brings performance-based CPC ads to the burgeoning world of AI chat.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

The Ft. Lauderdale bank posted a stunning 21.56% return on equity for 2025, but can it sustain the momentum in a competitive South Florida market?

WACKER is set to reveal a cost-saving XRF testing method and a breakthrough gamma-sterilizable medical adhesive, poised to impact two key sectors.

Indonesia's CIMB Niaga partners with AI Rudder, betting that advanced voice AI can enhance, not replace, human agents in the future of banking.

TytoCare’s groundbreaking AI for analyzing eardrums just got FDA De Novo clearance, creating a new category for at-home diagnostics and tackling a top pediatric issue.

CHINAPLAS 2026 preview reveals a strategic shift to bio-materials, smart factories, and deep alignment with China's ambitious industrial roadmap.

Unibail-Rodamco-Westfield defies retail caution with a 5% sales jump, major financing success, and a new sustainability standard, signaling robust growth.

The California bank raised its shareholder payout for the 19th straight year, reflecting robust financials and a conservative strategy in a shifting market.

Intel tops Q1 revenue forecasts with strong AI and data center sales, yet a massive $4.1B charge pushes it to a steep GAAP loss, revealing a costly path.

A new study reveals that poor muscle quality, measured by advanced MRI, is a powerful predictor of death in CKD patients, shifting focus to systemic health.

ASIFA-Hollywood's new initiative creates a direct pipeline from top international festivals to the Annie Awards, opening doors for global talent.

A firm co-founded by hedge fund titan Kyle Bass is buying up 'mitigation banks,' turning ecological restoration into a high-stakes investment.

Tradr ETFs launches inverse funds for Lumentum and Sandisk, offering sophisticated traders a powerful, high-risk tool to short popular tech names.

Jeni's Splendid Ice Creams hires former Ben & Jerry's CEO David Stever, signaling a major push for expansion. Can he scale the brand without losing its soul?